MRK vs ABBV
MRK and ABBV side by side — valuation & fundamentals (public data).
Key statistics
| Metric | MRKMerck & Co., Inc. | ABBVAbbVie Inc. |
|---|---|---|
| Market cap | $321.60B | $443.25B |
| P/E (TTM) | 36.7 | 123.6 |
| P/B | 7.01 | — |
| P/S | 5.0x | 7.3x |
| Dividend yield | 2.54% | 2.63% |
| Revenue | $65.77B(TTM) | $61.16B(TTM) |
| Revenue growth (YoY) | 1.3% | 8.6% |
| Net income | $8.94B(TTM) | $3.63B(TTM) |
| Earnings growth (YoY) | 6.6% | -1.2% |
| EPS, diluted | $3.55(TTM) | $2.03(TTM) |
| EBIT margin | 34.2% | 24.6% |
| ROE | 39.8% | — |
| ROIC | 21.5% | 20.0% |
| 1y total return | +71.3% | +38.0% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: MRK vs ABBV
| Metric | MRK | ABBV |
|---|---|---|
| End value | $33.5K | $67.6K |
| Total return | +235.1% | +575.8% |
| CAGR | +12.4% | +20.3% |
| Volatility | 22.9% | 25.8% |
| Sharpe | 0.46 | 0.70 |
| Sortino | 0.67 | 0.98 |
| Max drawdown | -43.4% | -45.1% |
Based on 2600 common trading days, 2016-03-30 → 2026-07-31 · risk-free 3.83% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)